Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 21:32 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Phase I Interaction Study of Istaroxime and Digoxin in Subjects With Stable Heart Failure
NCT00869115 · Debiopharm International SA · PHASE1 · withdrawn · last registry update 2014-10-23 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “The study was not started due to a re-evaluation of the istaroxime development program” | – | Registry record, Debiopharm International SA |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against ATP1A1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2015-09-09Phase 3 first posted: University of Monastir, Digoxin + Placebo (NCT02544815)
- 2015-08-10Results posted on the registry: Hoffmann-La Roche, Digoxin + Vemurafenib (NCT01765569)
- 2015-03-10Also stopped (withdrawn): Boehringer Ingelheim, Omeprazole + Warfarin (NCT02345304)
- 2015-01-26Results posted on the registry: Stanford University, Mifepristone + Misoprostol (NCT01615731)
- 2014-12-31Results posted on the registry: Bial - Portela C S.A., BIA 2-093 + Placebo (NCT02172742)
- 2014-11-10Results posted on the registry: University of Louisville, Erlotinib plus Digoxin (NCT00281021)
- 2014-10-23Also stopped (withdrawn): Debiopharm International SA, Istaroxime + Istaroxime (NCT00838253)
- 2014-10-07Results posted on the registry: Eli Lilly and Company, Digoxin + Dulaglutide (NCT01436201)
- 2014-08-08Results posted on the registry: BTG International Inc., Anti-digoxin antibody (FAB fragment) (NCT00158743)
- 2014-06-17Results posted on the registry: Boehringer Ingelheim, Digoxin plus BI 10773 + Digoxin (NCT01306175)
- 2014-06-05Results posted on the registry: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Digoxin (NCT01162135)
- 2014-05-19Results posted on the registry: University of Illinois Chicago, Digoxin (NCT01005602)
- 2014-05-07Phase 3 first posted: Icahn School of Medicine at Mount Sinai, Amiodarone + Rate Control (NCT02132767)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision